The Second Revision of the Dopamine Theory of Schizophrenia: Implications for Treatment and Drug Development
暂无分享,去创建一个
[1] J. Stevens. An anatomy of schizophrenia? , 1973, Archives of general psychiatry.
[2] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[3] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[4] T. Lidsky. Reevaluation of the mesolimbic hypothesis of antipsychotic drug action. , 1995, Schizophrenia bulletin.
[5] M. Laruelle,et al. Glutamate, Dopamine, and Schizophrenia , 2003 .
[6] Marie-Claude Asselin,et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. , 2009, Archives of general psychiatry.
[7] S. Haber,et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. , 2010, Archives of general psychiatry.
[8] P. McGuire,et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. , 2012, Archives of general psychiatry.
[9] Mark Slifstein,et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.
[10] A. Egerton,et al. Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort , 2013, Biological Psychiatry.